The history of Viagra presents a nuanced case for observers in the medicinal sector. While initially a blockbuster success, creating huge profits, the intellectual property expiration and the subsequent flood of off-brand competitors have considerably changed revenue. This presents questions about the future sustainability of similar drug projects